Serum IgM antibodies to LOS from BD-39 antibodies were found in 20% of GBS patients, in 4% of OND controls (p = 0.088) and in 0% of family controls (p = 0.025) (data not shown). This evidence concerns the gene CD40LG and Guillain-Barre syndrome.